Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast…

Overview of attention for article published in Journal of Translational Medicine, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 33 Dimensions

Readers on

mendeley: 72 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,456 followers.

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer. https://t.co/mrCpwiO3At

06 Apr 2018

Reply Repost Favourite

Study shows high #CFR leads to high #ORR & long #PFS under #TPD regimen in #HER2-#PositiveBreastCancer & CFR may become one of prognostic factors. Koji Takada, MD et al Journal of Translational Medicine https://t.co/LgPZvydAxN

04 Apr 2018

Reply Repost Favourite

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting… https://t.co/XPlsoPAhGJ #JTransMed

04 Apr 2018

Reply Repost Favourite